Stock TAUG TAURIGA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Tauriga Sciences, Inc.

Equities

TAUG

US87669X2053

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tauriga Sciences : Amendment to Late Filing Notice (Form NT 10-K/A)
PU
FindThisBest Selects Tauri-Gum as The #1 Best Kosher Chewing Gum in the Overall Marketplace
AQ
Tauriga Sciences Inc. Chief Executive Officer Completes 1,500,000 Share Insider Purchase
AQ
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order
GL
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order
CI
Tauriga Sciences Inc. Invited to Participate in the Upcoming Kroger “Merchandising Planogram and Sales Planning” Event
GL
TAURIGA SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
Tauriga Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
Tauriga Sciences Inc. Receives its 9,000th E-Commerce Order
CI
Tauriga Sciences Inc. Generates Record Quarterly Net Revenue, from Both Amazon and E-Commerce Business Segment
GL
Tauriga Sciences Inc. Receives Product Endorsement From the State of Alaska
GL
Tauriga Sciences Inc. Receives Product Endorsement from the State of Alaska
CI
Tauriga Sciences Inc. Set to Report Record Quarterly Net Revenue
GL
Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review Board
CI
Tauriga Sciences, Inc. Appoints Matthew A. Shaw as Member of Its Corporate Advisory Board
AQ
Tauriga Sciences, Inc. Appoints Matthew A. Shaw as Member of its Corporate Advisory Board
CI
Tauriga Sciences : Announces Results of Special Meeting of Shareholders Held on November 22, 2021 - Form 8-K
PU
TAURIGA SCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Tauriga Sciences, Inc. Announces Results of Special Meeting of Shareholders Held on November 22, 2021
GL
Clinical Validation is Completed for New COVID-19 Assay Designed by AEGEA Biotechnologies; Test Quantifies Viral Load to Determine Infection Level and Disease Progression
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TAUG Stock
  4. News Tauriga Sciences, Inc.